The advertisement promotes ENTYVIO as a superior treatment option compared to HUMIRA for adults with moderately to severely active ulcerative colitis, highlighting clinical efficacy and important safety information.
Creative Information
| CID: | bad57fc0-2068-40f8-8b9d-16f39be527f3 |
| CRID: | 82_6854-929742 |
| Domain: | entyviohcp.com |
| Seat: | PP |
| Size: | 728x90 |
| Bid: | $3.19 |
| Timestamp: | 11/18/2025, 9:26:12 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/18/2025, 11:50:04 PM | 6.17s | |
| adomain_analysis | success | 11/19/2025, 2:49:56 AM | 3.81s | |
| adomain_capture | success | 11/19/2025, 2:49:52 AM | 0.09s | |
| ad_render | success | 11/18/2025, 11:49:58 PM | 24.65s | |
| brand_mapping | success | 11/18/2025, 11:50:00 PM | 1.61s | |
Analysis Results
Ad Format: banner
Brands: Entyvio
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1493.12 KB | ||||||||||||||||||||||
| Render Time: | 8.95 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1493.24 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives
